Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kolkhof

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|October 11, 1992
Specificities of three tight-binding Lac repressorsP Kolkhof
Nature|June 23, 1994
DNA recognition and the codeB Müller-Hill, P Kolkhof
Journal of Molecular Biology|September 9, 1994
Lambda cI repressor mutants altered in transcriptional activationP Kolkhof, B Müller-Hill
Journal of Molecular Biology|March 31, 1995
A basic tail increases repression by dimeric lac repressorP Kolkhof, S Oehler, R Alex, et al.
Journal of Endocrinological Investigation|July 17, 2021
Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonistsV Marzolla, A Feraco, F Limana, et al.
The EMBO Journal|July 15, 1994
Quality and position of the three lac operators of E. coli define efficiency of repressionS Oehler, M Amouyal, P Kolkhof, et al.
The EMBO Journal|August 1, 1992
Lac repressor with the helix-turn-helix motif of lambda cro binds to lac operatorP Kolkhof, D Teichmann, B Kisters-Woike, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 23, 2010
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonistsN Schupp, N Queisser, M Wolf, et al.
British Journal of Pharmacology|April 29, 2010
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptorF Wunder, H Tinel, R Kast, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factorsM Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|October 11, 1992
Specificities of three tight-binding Lac repressorsP Kolkhof
Nature|June 23, 1994
DNA recognition and the codeB Müller-Hill, P Kolkhof
Journal of Molecular Biology|September 9, 1994
Lambda cI repressor mutants altered in transcriptional activationP Kolkhof, B Müller-Hill
Journal of Molecular Biology|March 31, 1995
A basic tail increases repression by dimeric lac repressorP Kolkhof, S Oehler, R Alex, et al.
Journal of Endocrinological Investigation|July 17, 2021
Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonistsV Marzolla, A Feraco, F Limana, et al.
The EMBO Journal|July 15, 1994
Quality and position of the three lac operators of E. coli define efficiency of repressionS Oehler, M Amouyal, P Kolkhof, et al.
The EMBO Journal|August 1, 1992
Lac repressor with the helix-turn-helix motif of lambda cro binds to lac operatorP Kolkhof, D Teichmann, B Kisters-Woike, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 23, 2010
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonistsN Schupp, N Queisser, M Wolf, et al.
British Journal of Pharmacology|April 29, 2010
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptorF Wunder, H Tinel, R Kast, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factorsM Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Pageof 1